Announced
Completed
Financials
Sources
Tags
Acquisition
Completed
Majority
nutritional products
Domestic
Private Equity
Friendly
biopharmaceuticals
Private
Pharmaceuticals
United States
Single Bidder
Synopsis
Nexxus Iberia, agreed to acquire Solutex, a producer Omega 3 natural ingredients from fish and algae oils, which are mainly used for pharma and food supplement products. Financial terms were not disclosed. Nexxus Iberia’s investment will allow Solutex to expand its manufacturing plant in Mallén (Aragón) to face the increasing demand. Likewise, the capital increase will accelerate the ongoing integration of Solutex’s production process. This will allow the Company to expand its innovation capabilities, which will be materialised in the launching of new highly concentrated Omega 3 bioactive products.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.